# TIAM1

## Overview
TIAM1 (T-cell lymphoma invasion and metastasis 1) is a gene that encodes the TIAM Rac1 associated GEF 1 protein, a guanine nucleotide exchange factor (GEF) primarily involved in the activation of Rac1, a member of the Rho family of GTPases. This protein plays a pivotal role in regulating the actin cytoskeleton, influencing cell morphology, motility, and adhesion. TIAM1 is characterized by several functional domains, including Dbl homology (DH) and pleckstrin homology (PH) domains, which are essential for its GEF activity, as well as a PSD-95-Dlg-ZO-1 (PDZ) domain that facilitates protein-protein interactions and membrane localization (Engers2000Tiam1; Xu2024Autoinhibition). The protein is involved in various cellular processes, such as neuronal development, epithelial cell integrity, and phagocytosis, by modulating Rac1 activity (Leeuwen1997The; Peotter2016Involvement). Clinically, TIAM1 is implicated in cancer progression and metastasis, with its overexpression linked to poor prognosis in several cancers, including ovarian, prostate, and colorectal cancers (Li2016Clinical; Izumi2019TIAM1; Engers2006Prognostic).

## Structure
The TIAM1 protein is a guanine nucleotide exchange factor (GEF) that primarily activates Rac1, a member of the Rho family of GTPases. It is composed of 1,591 amino acids and has a molecular weight of approximately 177 kDa (Engers2000Tiam1; Xu2024Autoinhibition). The protein contains several important domains, including a Dbl homology (DH) domain and two pleckstrin homology (PH) domains, which are crucial for its function as a GEF (Engers2000Tiam1). The DH domain, in combination with the COOH-terminally flanking PH domain, facilitates the exchange of GDP for GTP on Rac1, thereby activating it (Xu2024Autoinhibition).

TIAM1 also features a PSD-95-Dlg-ZO-1 (PDZ) domain, which is involved in protein-protein interactions and membrane localization (Engers2000Tiam1). The N-terminal region includes a myristoylation site and two PEST domains, which are associated with protein degradation and stability (Xu2024Autoinhibition). The PH-CC-Ex domain is involved in auto-inhibition of the GEF activity and membrane targeting (Terawaki2008Crystallographic; Xu2024Autoinhibition).

Post-translational modifications, such as phosphorylation, play a role in regulating TIAM1's activity and interactions (Xu2024Autoinhibition). Multiple splice variants of TIAM1 exist, contributing to its functional diversity (Lin2022TIAM1). These structural features enable TIAM1 to participate in various cellular processes, including cytoskeletal dynamics and signal transduction.

## Function
TIAM1 (TIAM Rac1 associated GEF 1) is a guanine nucleotide exchange factor (GEF) that specifically activates the small GTPase Rac1, playing a crucial role in various cellular processes. In healthy human cells, TIAM1 is involved in the regulation of the actin cytoskeleton, which is essential for cell morphology, motility, and adhesion. It facilitates the localized activation of Rac1 at sites of newly attached integrins, promoting actin polymerization and membrane extension, which are critical for cell migration (O’Toole2011Tiam1).

TIAM1 also plays a significant role in neuronal development by influencing neuronal morphology. It activates Rac1, leading to changes in cell shape and the formation of neurite-like processes, which are important for neuronal differentiation and function (Leeuwen1997The). In epithelial cells, TIAM1/Rac signaling can promote either cell-cell adhesion or cell migration, depending on the extracellular matrix. This matrix-dependent signaling is regulated by phosphatidylinositol 3-kinase (PI3-kinase), highlighting TIAM1's role in maintaining epithelial cell integrity and function (Sander1998Matrix-dependent).

Additionally, TIAM1 is involved in Rac1-mediated phagocytosis in human trabecular meshwork cells, where it acts as a GEF to activate Rac1, crucial for actin cytoskeleton reorganization during phagocytosis (Peotter2016Involvement).

## Clinical Significance
TIAM1 is implicated in various cancers due to its role in cell signaling pathways that influence tumor progression and metastasis. In serous ovarian carcinoma, TIAM1 overexpression is associated with high-grade tumors, metastasis, and advanced FIGO stages, correlating with lower overall survival rates, making it a potential independent biomarker for poor prognosis (Li2016Clinical). In prostate cancer, TIAM1 is significantly overexpressed in high-grade prostatic intraepithelial neoplasia and prostate carcinomas, where it predicts decreased disease-free survival and is linked to disease recurrence and lymph vessel invasion (Engers2006Prognostic).

In colorectal cancer, TIAM1 upregulation contributes to chemoresistance and tumor invasiveness. High expression levels are associated with poor response to chemotherapy and worse survival outcomes, suggesting its role as an independent prognostic factor (Izumi2019TIAM1). In lung adenocarcinoma, TIAM1 overexpression correlates with poor histological differentiation, advanced TNM stage, and lymph node metastasis, serving as an independent risk factor for poor prognosis (Zhu2019&lt; The; p&gt).

Mutations in TIAM1, such as the A441G mutation, have been identified in renal cell carcinomas, potentially contributing to tumor progression by affecting the gene's function in cell invasion (Engers2000Tiam1).

## Interactions
TIAM1, a guanine nucleotide exchange factor, primarily interacts with the small GTPase Rac1, facilitating its activation. This interaction is mediated through specific helices and residues in TIAM1, with the CR3 helix being particularly crucial for binding to Rac1 (Contini2018Peptide). Molecular dynamics simulations have identified key residues in Rac1's switch domains that are critical for its interaction with TIAM1 (Zheng2021Computational).

TIAM1 also interacts with scaffold proteins such as IB2/JIP2, which are involved in the p38 MAP kinase signaling pathway. This interaction enhances the activation of the p38 MAP kinase cascade, indicating a specificity in signaling pathways (Buchsbaum2002Interaction). The binding of TIAM1 to IB2/JIP2 facilitates the assembly of a signaling complex that enhances p38 activation, but not Jnk activation, suggesting a role in organizing specific signaling pathways (Buchsbaum2002Interaction).

Additionally, TIAM1's interaction with phosphoinositides, particularly through its pleckstrin homology domains, is crucial for its activation and membrane localization. This interaction enhances TIAM1's GDP/GTP exchange activity, further influencing its regulatory functions (FLEMING2000Regulation). These interactions highlight TIAM1's role in various cellular processes, including cell migration and cytoskeletal organization.


## References


[1. (Peotter2016Involvement) Jennifer L. Peotter, Jenny Phillips, Tiegang Tong, Kaylee Dimeo, Jose M. Gonzalez, and Donna M. Peters. Involvement of tiam1, rhog and elmo2/ilk in rac1-mediated phagocytosis in human trabecular meshwork cells. Experimental Cell Research, 347(2):301–311, October 2016. URL: http://dx.doi.org/10.1016/j.yexcr.2016.08.009, doi:10.1016/j.yexcr.2016.08.009. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2016.08.009)

[2. (Leeuwen1997The) Frank N. van Leeuwen, Hendrie E.T. Kain, Rob A. van der Kammen, Frits Michiels, Onno W. Kranenburg, and John G. Collard. The guanine nucleotide exchange factor tiam1 affects neuronal morphology; opposing roles for the small gtpases rac and rho. The Journal of Cell Biology, 139(3):797–807, November 1997. URL: http://dx.doi.org/10.1083/jcb.139.3.797, doi:10.1083/jcb.139.3.797. This article has 300 citations.](https://doi.org/10.1083/jcb.139.3.797)

[3. (Li2016Clinical) Huiwen Li, Xuelian Cui, Dingbao Chen, Yang Yang, Junjie Piao, Zhenhua Lin, Guanghai Yan, and Danhua Shen. Clinical implication of tiam1 overexpression in the prognosis of patients with serous ovarian carcinoma. Oncology Letters, 12(5):3492–3498, September 2016. URL: http://dx.doi.org/10.3892/ol.2016.5091, doi:10.3892/ol.2016.5091. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2016.5091)

[4. (FLEMING2000Regulation) Ian N. FLEMING, Alexander GRAY, and C. Peter DOWNES. Regulation of the rac1-specific exchange factor tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components. Biochemical Journal, 351(1):173, October 2000. URL: http://dx.doi.org/10.1042/0264-6021:3510173, doi:10.1042/0264-6021:3510173. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/0264-6021:3510173)

[5. (O’Toole2011Tiam1) Timothy E. O’Toole, Katarzyna Bialkowska, Xiaohong Li, and Joan E.B. Fox. Tiam1 is recruited to β1‐integrin complexes by 14‐3‐3ζ where it mediates integrin‐induced rac1 activation and motility. Journal of Cellular Physiology, 226(11):2965–2978, August 2011. URL: http://dx.doi.org/10.1002/jcp.22644, doi:10.1002/jcp.22644. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcp.22644)

[6. (Izumi2019TIAM1) Daisuke Izumi, Shusuke Toden, Elsie Ureta, Takatsugu Ishimoto, Hideo Baba, and Ajay Goel. Tiam1 promotes chemoresistance and tumor invasiveness in colorectal cancer. Cell Death &amp; Disease, March 2019. URL: http://dx.doi.org/10.1038/s41419-019-1493-5, doi:10.1038/s41419-019-1493-5. This article has 51 citations.](https://doi.org/10.1038/s41419-019-1493-5)

[7. (Contini2018Peptide) Alessandro Contini, Nicola Ferri, Raffaella Bucci, Maria Giovanna Lupo, Emanuela Erba, Maria Luisa Gelmi, and Sara Pellegrino. Peptide modulators of rac1/tiam1 protein‐protein interaction: an alternative approach for cardiovascular diseases. Peptide Science, February 2018. URL: http://dx.doi.org/10.1002/bip.23089, doi:10.1002/bip.23089. This article has 21 citations.](https://doi.org/10.1002/bip.23089)

[8. (Engers2000Tiam1) Rainer Engers, Thomas P. Zwaka, Lutz Gohr, Achim Weber, Claus-Dieter Gerharz, and Helmut E. Gabbert. Tiam1 mutations in human renal-cell carcinomas. International Journal of Cancer, 88(3):369–376, 2000. URL: http://dx.doi.org/10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K, doi:10.1002/1097-0215(20001101)88:3<369::aid-ijc8>3.0.co;2-k. This article has 136 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/1097-0215(20001101)88:3)

9. (Xu2024Autoinhibition) Auto-inhibition mechanism of the guanine nucleotide exchange factor Tiam1. This article has 0 citations.

[10. (Buchsbaum2002Interaction) Rachel J. Buchsbaum, Beth A. Connolly, and Larry A. Feig. Interaction of rac exchange factors tiam1 and ras-grf1 with a scaffold for the p38 mitogen-activated protein kinase cascade. Molecular and Cellular Biology, 22(12):4073–4085, June 2002. URL: http://dx.doi.org/10.1128/mcb.22.12.4073-4085.2002, doi:10.1128/mcb.22.12.4073-4085.2002. This article has 156 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.22.12.4073-4085.2002)

[11. (Lin2022TIAM1) Chih-Hsien Lin, Ying-Chun Chen, Shih-Peng Chan, and Chan-Yen Ou. Tiam-1 differentially regulates dendritic and axonal microtubule organization in patterning neuronal development through its multiple domains. PLOS Genetics, 18(10):e1010454, October 2022. URL: http://dx.doi.org/10.1371/journal.pgen.1010454, doi:10.1371/journal.pgen.1010454. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1010454)

[12. (Terawaki2008Crystallographic) Shin-ichi Terawaki, Ken Kitano, and Toshio Hakoshima. Crystallographic characterization of the membrane-targeting domains of the rac-specific guanine nucleotide-exchange factors tiam1 and tiam2. Acta Crystallographica Section F Structural Biology and Crystallization Communications, 64(11):1039–1042, October 2008. URL: http://dx.doi.org/10.1107/s1744309108031692, doi:10.1107/s1744309108031692. This article has 2 citations.](https://doi.org/10.1107/s1744309108031692)

[13. (Zheng2021Computational) Chunwen Zheng, Xiaodong Wu, Ruijie Zeng, Lirui Lin, Liyan Xu, Enmin Li, and Geng Dong. Computational prediction of hot spots and binding site of inhibitor nsc23766 on rac1 binding with tiam1. Frontiers in Chemistry, February 2021. URL: http://dx.doi.org/10.3389/fchem.2020.625437, doi:10.3389/fchem.2020.625437. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fchem.2020.625437)

[14. (Sander1998Matrix-dependent) Eva E. Sander, Sanne van Delft, Jean P. ten Klooster, Tim Reid, Rob A. van der Kammen, Frits Michiels, and John G. Collard. Matrix-dependent tiam1/rac signaling in epithelial cells promotes either cell–cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. The Journal of Cell Biology, 143(5):1385–1398, November 1998. URL: http://dx.doi.org/10.1083/jcb.143.5.1385, doi:10.1083/jcb.143.5.1385. This article has 812 citations.](https://doi.org/10.1083/jcb.143.5.1385)

[15. (Engers2006Prognostic) R Engers, M Mueller, A Walter, J G Collard, R Willers, and H E Gabbert. Prognostic relevance of tiam1 protein expression in prostate carcinomas. British Journal of Cancer, 95(8):1081–1086, September 2006. URL: http://dx.doi.org/10.1038/sj.bjc.6603385, doi:10.1038/sj.bjc.6603385. This article has 57 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.bjc.6603385)